102 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Wang JH, Chen CH, Chang CM, Feng WC, Lee CY, Lu SN. Hepatitis C virus core antigen is cost-effective in community-based screening of active hepatitis C infection in Taiwan. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 31350109 DOI: 10.1016/j.jfma.2019.07.011  0.44
2019 Yen YH, Kuo FY, Chen CH, Hu TH, Lu SN, Wang JH, Hung CH. Ultrasound is highly specific in diagnosing compensated cirrhosis in chronic hepatitis C patients in real world clinical practice. Medicine. 98: e16270. PMID 31277150 DOI: 10.1097/MD.0000000000016270  0.44
2019 Chen CH, Chen CH, Lin CL, Lin CY, Hu TH, Tung SY, Hsieh SY, Lu SN, Chien RN, Hung CH, Sheen IS. Real-world safety and efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir ± ribavirin in patients with hepatitis C virus genotype 1 and advanced hepatic fibrosis or compensated cirrhosis: a multicenter pooled analysis. Scientific Reports. 9: 7086. PMID 31068655 DOI: 10.1038/s41598-019-43554-3  0.44
2019 Lee YC, Hu TH, Hung CH, Lu SN, Chen CH, Wang JH. The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals. Plos One. 14: e0214323. PMID 30939158 DOI: 10.1371/journal.pone.0214323  0.44
2019 Chen YH, Lu SN, Wang JH, Hung CH, Hu TH, Chen CH. Pre-S/Surface and Core Promoter/Precore Mutations in Chronic Hepatitis B Patients with Severe Acute Exacerbation. Digestive Diseases and Sciences. PMID 30835025 DOI: 10.1007/s10620-019-05571-0  0.44
2019 Chen CH, Hung CH, Wang JH, Lu SN, Lai HC, Hu TH, Lin CH, Peng CY. The Incidence of Hepatitis B Surface Antigen Loss Between Hepatitis B E Antigen-Negative Noncirrhotic Patients Who Discontinued or Continued Entecavir Therapy. The Journal of Infectious Diseases. PMID 30689910 DOI: 10.1093/infdis/jiy697  0.44
2019 Yen YH, Kee KM, Chen CH, Hu TH, Lu SN, Wang JH, Hung CH. Sustained virological response and metabolic risk factors are associated with mortality in patients with chronic hepatitis C. Plos One. 14: e0208858. PMID 30625158 DOI: 10.1371/journal.pone.0208858  0.44
2018 Yen YH, Kee KM, Kuo FY, Chang KC, Hu TH, Lu SN, Wang JH, Hung CH, Chen CH. A scoring system to predict HBsAg seroclearance in hepatitis B and C coinfected patients treated with interferon and ribavirin in an Asian cohort. Medicine. 97: e13383. PMID 30557991 DOI: 10.1097/MD.0000000000013383  0.44
2018 Sou FM, Wu CK, Chang KC, Lu SN, Wang JH, Hung CH, Chen CH, Kee KM, Yen YH, Lin MT, Tsai MC, Hu TH. Clinical characteristics and prognosis of HCC occurrence after antiviral therapy for HCV patients between sustained and non-sustained responders. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 30527565 DOI: 10.1016/j.jfma.2018.10.017  0.44
2018 Chien RN, Kao JH, Peng CY, Chen CH, Liu CJ, Huang YH, Hu TH, Yang HI, Lu SN, Ni YH, Chuang WL, Lee CM, Wu JC, Chen PJ, Liaw YF. Taiwan consensus statement on the management of chronic hepatitis B. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 30527436 DOI: 10.1016/j.jfma.2018.11.008  0.44
2018 Chang PY, Huang CC, Hung CH, Yu CY, Wu DK, Hwang JI, Liang PC, Wu RH, Tsai WL, Lin YJ, Liu YS, Liang HL, Lee RC, Chen CH. Multidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma Treatment. Liver Cancer. 7: 312-322. PMID 30488021 DOI: 10.1159/000487608  0.36
2018 Kuo MT, Hu TH, Hung CH, Wang JH, Lu SN, Tsai KL, Chen CH. Hepatitis B virus relapse rates in chronic hepatitis B patients who discontinue either entecavir or tenofovir. Alimentary Pharmacology & Therapeutics. PMID 30484881 DOI: 10.1111/apt.15053  0.44
2018 Yen YH, Kuo FY, Kee KM, Chang KC, Tsai MC, Hu TH, Lu SN, Wang JH, Hung CH, Chen CH. Diabetes is associated with advanced fibrosis and fibrosis progression in non-genotype 3 chronic hepatitis C patients. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. PMID 30076015 DOI: 10.1016/j.dld.2018.07.003  0.44
2018 Liao SH, Su TH, Jeng YM, Liang PC, Chen DS, Chen CH, Kao JH. Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma. Hepatology (Baltimore, Md.). PMID 30014620 DOI: 10.1002/hep.30162  0.36
2018 Wang HW, Lai HC, Hu TH, Su WP, Lu SN, Lin CH, Hung CH, Chuang PH, Wang JH, Lee MH, Chen CH, Peng CY. Modified FIB-4 index stratifies hepatocellular carcinoma risk in chronic hepatitis B patients on entecavir therapy. Journal of Gastroenterology and Hepatology. PMID 29968933 DOI: 10.1111/jgh.14372  0.44
2018 Yen YH, Kuo FY, Kee KM, Chang KC, Tsai MC, Hu TH, Lu SN, Wang JH, Hung CH, Chen CH. APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level. Plos One. 13: e0199760. PMID 29953518 DOI: 10.1371/journal.pone.0199760  0.44
2018 Chiang HH, Lee CM, Hu TH, Hung CH, Wang JH, Lu SN, Lai HC, Su WP, Lin CH, Peng CY, Chen CH. A combination of the on-treatment FIB-4 and alpha-fetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavir. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 29797410 DOI: 10.1111/liv.13889  0.44
2018 Kuo MT, Tseng PL, Chou YP, Chang KC, Tsai MC, Kuo YH, Hu TH, Hung CH, Wang JH, Lu SN, Chen CH. The role of HBsAg in HBV relapse after entecavir or tenofovir prophylaxis in patients undergoing cancer chemotherapy. Journal of Gastroenterology and Hepatology. PMID 29514418 DOI: 10.1111/jgh.14142  0.44
2017 Chen CH, Hung CH, Wang JH, Lu SN, Hu TH, Lee CM. Long-term incidence and predictors of hepatitis B surface antigen loss after discontinuing nucleoside analogues in non-cirrhotic chronic hepatitis B patients. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 29288020 DOI: 10.1016/j.cmi.2017.12.013  0.44
2017 Chen CH, Hsu YC, Lu SN, Hung CH, Wang JH, Lee CM, Hu TH. The incidence and predictors of HBV relapse after cessation of tenofovir therapy in chronic hepatitis B patients. Journal of Viral Hepatitis. PMID 29274189 DOI: 10.1111/jvh.12851  0.44
2017 Chen CH, Lee CM, Lai HC, Hu TH, Su WP, Lu SN, Lin CH, Hung CH, Wang JH, Lee MH, Peng CY. Prediction model of hepatocellular carcinoma risk in Asian patients with chronic hepatitis B treated with entecavir. Oncotarget. 8: 92431-92441. PMID 29190928 DOI: 10.18632/oncotarget.21369  0.44
2017 Yen YH, Lin MT, Kuo FY, Chang KC, Tsai MC, Tseng PL, Wu CK, Lin JT, Hu TH, Lu SN, Wang JH, Hung CH, Chen CH. The association between steatosis and diabetes with hepatocellular carcinoma in non-genotype 3 chronic hepatitis C patients. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 29164767 DOI: 10.1111/liv.13633  0.44
2017 Huang CM, Hu TH, Chang KC, Tseng PL, Lu SN, Chen CH, Wang JH, Lee CM, Tsai MC, Lin MT, Yen YH, Hung CH, Cho CL, Wu CK. Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy: Prioritize who needs urgent direct-acting antiviral agents. Medicine. 96: e8696. PMID 29145306 DOI: 10.1097/MD.0000000000008696  0.44
2017 Yen YH, Tsai MC, Wu CK, Chang KC, Hung CH, Chiu KW, Lu SN, Wang JH, Chen CH, Kee KM, Kuo YH, Tseng PL, Lin MT, Huang CM, Lin JT, et al. Association between PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma in Asian chronic hepatitis C patients: A longitudinal study. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 29089161 DOI: 10.1016/j.jfma.2017.10.003  0.44
2017 Yen YH, Chang KC, Tsai MC, Tseng PL, Lin MT, Wu CK, Lin JT, Hu TH, Wang JH, Chen CH. Elevated body mass index is a risk factor associated with possible liver cirrhosis across different etiologies of chronic liver disease. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 28947134 DOI: 10.1016/j.jfma.2017.09.002  0.44
2017 Huang CM, Chang KC, Hung CH, Chiu KW, Lu SN, Wang JH, Chen CH, Kee KM, Kuo YH, Tsai MC, Tseng PL, Lin MT, Wu CK, Hu TH, Cho CL, et al. Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C. Plos One. 12: e0182204. PMID 28797039 DOI: 10.1371/journal.pone.0182204  0.44
2017 Hung CH, Kee KM, Chen CH, Tseng PL, Tsai MC, Chen CH, Wang JH, Chang KC, Kuo YH, Yen YH, Hu TH, Lu SN. A Randomized Controlled Trial of Glycyrrhizin Plus Tenofovir vs. Tenofovir in Chronic Hepatitis B with Severe Acute Exacerbation. Clinical and Translational Gastroenterology. 8: e104. PMID 28662023 DOI: 10.1038/ctg.2017.29  0.44
2017 Yao CC, Hung CH, Hu TH, Lu SN, Wang JH, Lee CM, Chen CH. Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL. Scientific Reports. 7: 1839. PMID 28500322 DOI: 10.1038/s41598-017-02010-w  0.44
2017 Kuo YH, Wu IP, Wang JH, Hung CH, Rau KM, Chen CH, Kee KM, Hu TH, Lu SN. The outcome of sorafenib monotherapy on hepatocellular carcinoma with portal vein tumor thrombosis. Investigational New Drugs. PMID 28466374 DOI: 10.1007/s10637-017-0468-6  0.44
2017 Kuo YH, Wang JH, Hung CH, Rau KM, Wu IP, Chen CH, Kee KM, Hu TH, Lu SN. The ALBI grade predicts the prognosis of patients with advanced hepatocellular carcinoma received sorafenib. Journal of Gastroenterology and Hepatology. PMID 28295594 DOI: 10.1111/jgh.13783  0.44
2017 Wu IT, Hu TH, Hung CH, Lu SN, Wang JH, Lee CM, Chen CH. Comparison of the efficacy and safety of entecavir and tenofovir in nucleos(t)ide analogue-naïve chronic hepatitis B patients with high viremia: a retrospective cohort study. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 28189857 DOI: 10.1016/j.cmi.2017.02.001  0.44
2017 Hung CH, Wang JH, Lu SN, Hu TH, Lee CM, Chen CH. Hepatitis B surface antigen loss and clinical outcomes between HBeAg-negative cirrhosis patients who discontinued or continued nucleoside analog therapy. Journal of Viral Hepatitis. PMID 28130815 DOI: 10.1111/jvh.12683  0.44
2016 Chien TL, Wang JH, Kee KM, Chen CH, Hung CH, Lu SN. Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function. Plos One. 11: e0166543. PMID 27935953 DOI: 10.1371/journal.pone.0166543  0.44
2016 Tsai MC, Chen CH, Hu TH, Lu SN, Lee CM, Wang JH, Hung CH. Long-term outcomes of hepatitis B virus-related cirrhosis treated with nucleos(t)ide analogs. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 27720344 DOI: 10.1016/j.jfma.2016.08.006  0.44
2016 Yen YH, Huang CM, Wei KL, Wang JH, Lu SN, Lee CM, Hung CH, Chen CH, Tseng PL, Chang KC, Tsai MC, Lin MT, Wu CK, Yang CH, Moi SH, et al. MicroRNA-122 as a predictor of HBsAg seroclearance in hepatitis B and C dual infected patients treated with interferon and ribavirin. Scientific Reports. 6: 33816. PMID 27665934 DOI: 10.1038/srep33816  0.44
2016 Lee CM, Hu TH, Lu SN, Wang JH, Hung CH, Chen CH, Yen YH. Peripheral blood toll-like receptor 4 correlates with rapid virological response to pegylated-interferon and ribavirin therapy in hepatitis C genotype 1 patients. Bmc Gastroenterology. 16: 73. PMID 27457659 DOI: 10.1186/s12876-016-0492-6  0.44
2016 Wang JH, Yen YH, Yao CC, Hung CH, Chen CH, Hu TH, Lee CM, Lu SN. Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful anti-viral therapy. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 27254286 DOI: 10.1111/liv.13179  0.44
2016 Liu KL, Shih IL, Huang YC, Chen CH. Abdominoscrotal Hydrocele. The American Journal of Gastroenterology. 111: 312. PMID 27018108 DOI: 10.1038/ajg.2015.309  0.36
2016 Wu CK, Chang KC, Tseng PL, Lu SN, Chen CH, Wang JH, Lee CM, Lin MT, Yen YH, Hung CH, Hu TH. Comparison of Therapeutic Response and Clinical Outcome between HCV Patients with Normal and Abnormal Alanine Transaminase Levels. Plos One. 11: e0142378. PMID 26968010 DOI: 10.1371/journal.pone.0142378  0.44
2016 Tsai MC, Chen CH, Tseng PL, Hung CH, Chiu KW, Chang KC, Yen YH, Lin MT, Hu TH. Does Nucleos(t)ide Analogues Treatment Affect Renal Function in Chronic Hepatitis B Patients Who Have Already Decreased eGFR? A Longitudinal Study. Plos One. 11: e0149761. PMID 26964034 DOI: 10.1371/journal.pone.0149761  0.44
2016 Lee CM, Hu TH, Lu SN, Wang JH, Hung CH, Chen CH, Yen YH. Suppressor of cytokine signaling 1 expression in peripheral blood mononuclear cells of hepatitis C genotype 1 patients. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 26786212 DOI: 10.1016/j.jfma.2015.12.004  0.44
2016 Wang HM, Hung CH, Lee CM, Lu SN, Wang JH, Yen YH, Kee KM, Chang KC, Tseng PL, Hu TH, Chen CH. Three-year efficacy and safety of tenofovir in nucleos(t)ide analog-naïve and -experienced chronic hepatitis B patients. Journal of Gastroenterology and Hepatology. PMID 26758501 DOI: 10.1111/jgh.13294  0.44
2015 Hung CH, Hu TH, Lu SN, Chen CH, Wang JH, Lee CM. Association of vitamin D receptor gene polymorphisms with response to peginterferon plus ribavirin in Asian patients with chronic hepatitis C. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 26725771 DOI: 10.1016/j.jfma.2015.11.008  0.44
2015 Wang JH, Chen TY, Ou HY, Wang CC, Liu YW, Hung CH, Chen CH, Kuo CH, Hu TH, Cheng YF, Lu SN. Clinical Impact of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging on Hepatoma Management: A Prospective Study. Digestive Diseases and Sciences. PMID 26668057 DOI: 10.1007/s10620-015-3989-x  0.44
2015 Yeh JH, Hung CH, Wang JH, Chen CH, Kee KM, Kuo CM, Yen YH, Cheng YF, Chen YY, Hsu HC, Lu SN. Modifiable Prognostic Factors of Hepatocellular Carcinoma in Patients with Non-Surgical Treatment. Plos One. 10: e0144893. PMID 26661388 DOI: 10.1371/journal.pone.0144893  0.44
2015 Lee WC, Chen CH, Liu CY, Yu MS, Lin YH, Ong TG. Nickel-catalysed para-CH activation of pyridine with switchable regioselective hydroheteroarylation of allylarenes. Chemical Communications (Cambridge, England). PMID 26451893 DOI: 10.1039/c5cc07455j  0.36
2015 Hung CH, Hu TH, Lu SN, Kuo FY, Chen CH, Wang JH, Huang CM, Lee CM, Lin CY, Yen YH, Chiu YC. Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus. International Journal of Cancer. Journal International Du Cancer. PMID 26264553 DOI: 10.1002/ijc.29802  0.44
2015 Chen CH, Hung CH, Hu TH, Wang JH, Lu SN, Su PF, Lee CM. Association Between Level of Hepatitis B Surface Antigen and Relapse After Entecavir Therapy for Chronic HBV Infection. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 26073492 DOI: 10.1016/j.cgh.2015.06.002  0.44
2015 Hsu C, Chen BB, Chen CH, Ho MC, Cheng JC, Kokudo N, Murakami T, Yeo W, Seong J, Jia JD, Han KH, Cheng AL. Consensus Development from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014). Liver Cancer. 4: 96-105. PMID 26020032 DOI: 10.1159/000367732  0.36
2015 Hung CH, Hu TH, Lu SN, Lee CM, Chen CH, Kee KM, Wang JH, Tsai MC, Kuo YH, Chang KC, Chiu YC, Chen CH. Tenofovir versus entecavir in treatment of chronic hepatitis B virus with severe acute exacerbation. Antimicrobial Agents and Chemotherapy. 59: 3168-73. PMID 25779569 DOI: 10.1128/AAC.00261-15  0.44
2015 Tang SF, Chen CH, Wu CK, Hong WH, Chen KJ, Chen CK. The effects of total contact insole with forefoot medial posting on rearfoot movement and foot pressure distributions in patients with flexible flatfoot. Clinical Neurology and Neurosurgery. 129: S8-11. PMID 25683316 DOI: 10.1016/S0303-8467(15)30004-4  0.36
2015 Tang SF, Wu CK, Chen CH, Chen JT, Tang AC, Wu SH. Muscle activation features of the osteoarthritic knee with patellar lateral subluxation. Clinical Neurology and Neurosurgery. 129: S30-5. PMID 25683310 DOI: 10.1016/S0303-8467(15)30009-3  0.44
2015 Yao CC, Lee CM, Hung CH, Wang JH, Hu TH, Lu SN, Changchien CS, Hsu MC, Chen CH. Combining age and HBsAg level predicts post-treatment durability of nucleos(t)ide analogue-induced HBeAg seroconversion. Journal of Gastroenterology and Hepatology. 30: 918-24. PMID 25532588 DOI: 10.1111/jgh.12874  0.44
2015 Chung TY, Tsao CS, Tseng HP, Chen CH, Yu MS. Effects of oxygen functional groups on the enhancement of the hydrogen spillover of Pd-doped activated carbon. Journal of Colloid and Interface Science. 441: 98-105. PMID 25490569 DOI: 10.1016/j.jcis.2014.10.062  0.36
2015 Chang KC, Tseng PL, Wu YY, Hung HC, Huang CM, Lu SN, Wang JH, Lee CM, Chen CH, Tsai MC, Yen YH, Lin MT, Wu CK, Huang CC, Chen HH, et al. A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 13: 1017-24. PMID 25460552 DOI: 10.1016/j.cgh.2014.10.035  0.4
2015 Wang JH, Kee KM, Lin CY, Hung CH, Chen CH, Lee CM, Lu SN. Validation and modification of a proposed substaging system for patients with intermediate hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 30: 358-63. PMID 25088668 DOI: 10.1111/jgh.12686  0.44
2014 Chen CH, Lu SN, Lee CM, Hung CH, Wang JH, Hu TH. Patients with interferon-induced HBeAg seroconversion have a higher risk of HBV reactivation and HBeAg seroreversion. Hepatology International. 8: 365-74. PMID 26202639 DOI: 10.1007/s12072-014-9542-8  0.44
2014 Kuo MT, Hu TH, Lu SN, Hung CH, Wang JH, Chen CH, Chiu YC, Lee CM. Neutrophil-to-lymphocyte ratio as a predictor of response to peginterferon plus ribavirin therapy for chronic hepatitis C. Disease Markers. 2014: 462958. PMID 25505815 DOI: 10.1155/2014/462958  0.44
2014 Yang CH, Chiu YC, Chen CH, Chen CH, Tsai MC, Chuah SK, Lee CH, Hu TH, Hung CH. Diabetes mellitus is associated with gastroesophageal variceal bleeding in cirrhotic patients. The Kaohsiung Journal of Medical Sciences. 30: 515-20. PMID 25438683 DOI: 10.1016/j.kjms.2014.06.002  0.44
2014 Chen CH, Chiu YC, Lu SN, Lee CM, Wang JH, Hu TH, Hung CH. Serum hepatitis B surface antigen levels predict treatment response to nucleos(t)ide analogues. World Journal of Gastroenterology : Wjg. 20: 7686-95. PMID 24976706 DOI: 10.3748/wjg.v20.i24.7686  0.44
2014 Hung CH, Chiu YC, Hu TH, Chen CH, Lu SN, Huang CM, Wang JH, Lee CM. Significance of vitamin d receptor gene polymorphisms for risk of hepatocellular carcinoma in chronic hepatitis C. Translational Oncology. 7: 503-7. PMID 24894441 DOI: 10.1016/j.tranon.2014.05.001  0.44
2014 Kuo LF, Lee CM, Hung CH, Wang JH, Hu TH, Lu SN, Changchien CS, Chen CH. High risk of hepatitis B virus reactivation in nucleos(t)ide analogue-induced hepatitis B e antigen seroconverters older than 40 years. Digestive Diseases and Sciences. 59: 2580-7. PMID 24846794 DOI: 10.1007/s10620-014-3194-3  0.44
2014 Chang MC, Chen CH, Liang JD, Tien YW, Hsu C, Wong JM, Chang YT. Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma. World Journal of Gastroenterology : Wjg. 20: 5060-5. PMID 24803819 DOI: 10.3748/wjg.v20.i17.5060  0.36
2014 Hung CH, Chiu YC, Chen CH, Hu TH. MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target. Biomed Research International. 2014: 486407. PMID 24800233 DOI: 10.1155/2014/486407  0.44
2014 Chen CH, Lu SN, Hung CH, Wang JH, Hu TH, Changchien CS, Lee CM. The role of hepatitis B surface antigen quantification in predicting HBsAg loss and HBV relapse after discontinuation of lamivudine treatment. Journal of Hepatology. 61: 515-22. PMID 24798617 DOI: 10.1016/j.jhep.2014.04.029  0.44
2014 Chen CH, Hu TH, Hung CH, Wang JH, Lu SN, Lee CM. Antiviral effect of entecavir in nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients without virological response at week 24 or 48 of therapy. Journal of Viral Hepatitis. 21: e55-64. PMID 24766327 DOI: 10.1111/jvh.12239  0.44
2014 Tsai MC, Yu HC, Hung CH, Lee CM, Chiu KW, Lin MT, Tseng PL, Chang KC, Yen YH, Chen CH, Hu TH. Comparing the efficacy and clinical outcome of telbivudine and entecavir naïve patients with hepatitis B virus-related compensated cirrhosis. Journal of Gastroenterology and Hepatology. 29: 568-75. PMID 24716215 DOI: 10.1111/jgh.12436  0.44
2014 Kuo YH, Lu SN, Chen CH, Chang KC, Hung CH, Tai WC, Tsai MC, Tseng PL, Hu TH, Wang JH. The changes of liver stiffness and its associated factors for chronic hepatitis B patients with entecavir therapy. Plos One. 9: e93160. PMID 24682088 DOI: 10.1371/journal.pone.0093160  0.44
2014 Chen CH, Lin CL, Hu TH, Hung CH, Tseng PL, Wang JH, Chang JY, Lu SN, Chien RN, Lee CM. Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation. Journal of Hepatology. 60: 1127-34. PMID 24583247 DOI: 10.1016/j.jhep.2014.02.013  0.44
2014 Chen BB, Shih IL, Wu CH, Hsu C, Chen CH, Shih TT, Liu KL, Liang PC. Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies. Journal of Vascular and Interventional Radiology : Jvir. 25: 371-8. PMID 24468045 DOI: 10.1016/j.jvir.2013.10.027  0.36
2013 Chen CH, Hu TH, Hung CH, Lu SN, Wang JH, Chang MH, Changchien CS, Lee CM. A comparison of 4-year entecavir efficacy in nucleos(t)ide analog-naïve and -experienced adult Taiwanese chronic hepatitis B patients. Hepatology International. 7: 832-43. PMID 26201920 DOI: 10.1007/s12072-013-9440-5  0.44
2013 Yang SC, Lu SN, Lee CM, Hu TH, Wang JH, Hung CH, Changchien CS, Chen CH. Combining the HBsAg decline and HBV DNA levels predicts clinical outcomes in patients with spontaneous HBeAg seroconversion. Hepatology International. 7: 489-99. PMID 26201781 DOI: 10.1007/s12072-012-9382-3  0.44
2013 Chen CH, Lee CM, Wang JH, Hu TH, Hung CH, Changchien CS, Lu SN. Combination and evolution of HBV mutant strains in the HBeAg-positive status predict clinical outcomes after HBeAg seroconversion. Hepatology International. 7: 477-88. PMID 26201780 DOI: 10.1007/s12072-012-9381-4  0.44
2013 Yang SC, Wu KL, Wang JH, Lee CH, Kuo YH, Tai WC, Chen CH, Chiou SS, Lu SN, Hu TH, Changchien CS, Chuah SK. The effect of systemic antibiotic prophylaxis for cirrhotic patients with peptic ulcer bleeding after endoscopic interventions. Hepatology International. 7: 257-67. PMID 26201640 DOI: 10.1007/s12072-012-9378-z  0.44
2013 Wang JH, Hung CH, Kuo FY, Eng HL, Chen CH, Lee CM, Lu SN, Hu TH. Ultrasonographic quantification of hepatic-renal echogenicity difference in hepatic steatosis diagnosis. Digestive Diseases and Sciences. 58: 2993-3000. PMID 23828144 DOI: 10.1007/s10620-013-2769-8  0.44
2013 Liu YC, Hung CS, Wu YW, Lee YC, Lin YH, Lin C, Lo MT, Chan CC, Ma HP, Ho YL, Chen CH. Influence of non-alcoholic fatty liver disease on autonomic changes evaluated by the time domain, frequency domain, and symbolic dynamics of heart rate variability. Plos One. 8: e61803. PMID 23626730 DOI: 10.1371/journal.pone.0061803  0.36
2013 Yang SC, Lee CM, Hu TH, Wang JH, Lu SN, Hung CH, Changchien CS, Chen CH. Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutants. The Journal of Antimicrobial Chemotherapy. 68: 2154-63. PMID 23620466 DOI: 10.1093/jac/dkt147  0.44
2013 Hung CH, Hu TH, Lee CM, Huang CM, Chen CH, Wang JH, Lu SN. Amino acid substitutions in the core region associate with insulin resistance in chronic hepatitis C. Intervirology. 56: 166-71. PMID 23406967 DOI: 10.1159/000343913  0.44
2013 Wang HM, Hung CH, Lu SN, Chen CH, Lee CM, Hu TH, Wang JH. Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients. Liver International : Official Journal of the International Association For the Study of the Liver. 33: 756-61. PMID 23405889 DOI: 10.1111/liv.12118  0.44
2013 Wang JH, Chang KC, Kee KM, Chen PF, Yen YH, Tseng PL, Kuo YH, Tsai MC, Hung CH, Chen CH, Tai WC, Tsai LS, Chen SC, Lin SC, Lu SN. Hepatocellular carcinoma surveillance at 4- vs. 12-month intervals for patients with chronic viral hepatitis: a randomized study in community. The American Journal of Gastroenterology. 108: 416-24. PMID 23318478 DOI: 10.1038/ajg.2012.445  0.44
2013 Yu TY, Pang JH, Wu KP, Chen MJ, Chen CH, Tsai WC. Aging is associated with increased activities of matrix metalloproteinase-2 and -9 in tenocytes. Bmc Musculoskeletal Disorders. 14: 2. PMID 23281803 DOI: 10.1186/1471-2474-14-2  0.36
2013 Kee KM, Wang JH, Hung CH, Chen CH, Lee CM, Lu SN. Improvement of thrombocytopenia in hepatitis C-related advanced fibrosis patients after sustained virological response. Digestive Diseases and Sciences. 58: 556-61. PMID 23001404 DOI: 10.1007/s10620-012-2380-4  0.44
2013 Hung CH, Chang KC, Lu SN, Wang JH, Chen CH, Lee CM, Hu TH. Spontaneous clearance of hepatitis C virus in an interleukin 28B favorable genotype highly prevalent area. Hepatology (Baltimore, Md.). 57: 2089-90. PMID 22886694 DOI: 10.1002/hep.26002  0.44
2012 Tsai WL, Liang PC, Chen CH. Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 111: 724-5. PMID 23265753 DOI: 10.1016/j.jfma.2011.12.009  0.36
2012 Chang KC, Hung CH, Lu SN, Wang JH, Lee CM, Chen CH, Yen MF, Lin SC, Yen YH, Tsai MC, Tseng PL, Hu TH. A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapy. The Journal of Antimicrobial Chemotherapy. 67: 2766-72. PMID 22899800 DOI: 10.1093/jac/dks269  0.44
2012 Yu TY, Tsai WC, Cheng JW, Yang YM, Liang FC, Chen CH. The effects of aging on quantitative sonographic features of rotator cuff tendons. Journal of Clinical Ultrasound : Jcu. 40: 471-8. PMID 22508403 DOI: 10.1002/jcu.21919  0.36
2012 Kuo YH, Chang KC, Wang JH, Tsai PS, Hung SF, Hung CH, Chen CH, Lu SN. Is hepatitis C virus core antigen an adequate marker for community screening? Journal of Clinical Microbiology. 50: 1989-93. PMID 22461676 DOI: 10.1128/JCM.05175-11  0.44
2012 Wang JH, Chuah SK, Lu SN, Hung CH, Chen CH, Kee KM, Chang KC, Tai WC, Hu TH. Transient elastography and simple blood markers in the diagnosis of esophageal varices for compensated patients with hepatitis B virus-related cirrhosis. Journal of Gastroenterology and Hepatology. 27: 1213-8. PMID 22432969 DOI: 10.1111/j.1440-1746.2012.07132.x  0.44
2012 Chen CH, Wang JH, Lu SN, Hu TH, Hung CH, Chang MH, Changchien CS, Lee CM. Treatment response and evolution of HBV resistance during lamivudine plus adefovir or entecavir therapy in patients with adefovir-resistant mutants. Antiviral Therapy. 17: 701-9. PMID 22358132 DOI: 10.3851/IMP2074  0.44
2012 Tsai MC, Lee CM, Chiu KW, Hung CH, Tung WC, Chen CH, Tseng PL, Chang KC, Wang JH, Lu SN, Yen YH, Hu TH. A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice. The Journal of Antimicrobial Chemotherapy. 67: 696-9. PMID 22174039 DOI: 10.1093/jac/dkr495  0.44
2012 Hung CH, Chen CH, Lu SN, Wang JH, Hu TH, Huang CM, Tsai MC, Lee CM. Precore/core promoter mutations and hepatitis B virus genotype in hepatitis B and C dually infected patients treated with interferon-based therapy. Antiviral Research. 93: 55-63. PMID 22061616 DOI: 10.1016/j.antiviral.2011.10.018  0.44
2012 Kee KM, Wang JH, Hung CH, Chen CH, Lee CM, Chang KC, Tseng PL, Yen YH, Lin CY, Lu SN. Decreased anti-hepatitis C virus titer and associated factors in chronic hepatitis C patients after sustained virological response: a prospective study. Journal of Gastroenterology and Hepatology. 27: 1106-11. PMID 22004331 DOI: 10.1111/j.1440-1746.2011.06946.x  0.44
2012 Ch'ang HJ, Hsu C, Chen CH, Chang YH, Chang JS, Chen LT. Phase II study of concomitant thalidomide during radiotherapy for hepatocellular carcinoma. International Journal of Radiation Oncology, Biology, Physics. 82: 817-25. PMID 21277098 DOI: 10.1016/j.ijrobp.2010.10.067  0.36
2011 Hung CH, Lu SN, Wang JH, Hu TH, Chen CH, Huang CM, Lee CM. Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients. Antiviral Therapy. 16: 959-68. PMID 22024511 DOI: 10.3851/IMP1842  0.44
2011 Lee CM, Yen YH, Hung CH, Lu SN, Wang JH, Wang JC, Chen CH, Kee KM, Hu TH, Changchien CS. Liver interleukin-8 messenger RNA expression and interferon sensitivity-determining region mutations relate to treatment response in hepatitis C 1b. Antiviral Therapy. 16: 825-32. PMID 21900714 DOI: 10.3851/IMP1868  0.44
2011 Kuo YH, Chuang TW, Hung CH, Chen CH, Wang JH, Hu TH, Lu SN, Lee CM. Reversal of hypolipidemia in chronic hepatitis C patients after successful antiviral therapy. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 110: 363-71. PMID 21741004 DOI: 10.1016/S0929-6646(11)60054-5  0.44
2011 Chen CH, Lee CM, Hung CH, Wang JH, Hu TH, Changchien CS, Lu SN. Hepatitis B virus genotype B results in better immediate, late and sustained responses to peginterferon-alfa in hepatitis-B-e-antigen-positive patients. Journal of Gastroenterology and Hepatology. 26: 461-8. PMID 21332543 DOI: 10.1111/j.1440-1746.2010.06429.x  0.44
2011 Huang YC, Huang CF, Chang KC, Hung SF, Wang JH, Hung CH, Chen CH, Tseng PL, Kee KM, Yen YH, Tsai PS, Tsai CC, Lu SN. Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area. Journal of Gastroenterology and Hepatology. 26: 129-34. PMID 21175806 DOI: 10.1111/j.1440-1746.2010.06476.x  0.44
2011 Chen CH, Wang JH, Lu SN, Hu TH, Hung CH, Chang MH, Changchien CS, Lee CM. Characteristics of adefovir resistance in patients with or without lamivudine-resistant hepatitis B virus treated with adefovir: a 4-year experience. Liver International : Official Journal of the International Association For the Study of the Liver. 31: 206-14. PMID 21143368 DOI: 10.1111/j.1478-3231.2010.02416.x  0.44
2011 Tsai PS, Chang CJ, Chen KT, Chang KC, Hung SF, Wang JH, Hung CH, Chen CH, Tseng PL, Kee KM, Yen YH, Tsai CC, Lu SN. Acquirement and disappearance of HBsAg and anti-HCV in an aged population: a follow-up study in an endemic township. Liver International : Official Journal of the International Association For the Study of the Liver. 31: 971-9. PMID 21054768 DOI: 10.1111/j.1478-3231.2010.02363.x  0.44
2010 Kuo YH, Lu SN, Hung CH, Kee KM, Chen CH, Hu TH, Lee CM, Changchien CS, Wang JH. Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis. Hepatology International. 4: 700-6. PMID 21286340 DOI: 10.1007/s12072-010-9223-1  0.44
2010 Chen JY, Wang JH, Lin CY, Chen PF, Tseng PL, Chen CH, Chang KC, Tsai LS, Chen SC, Lu SN. Lower prevalence of hypercholesterolemia and hyperglyceridemia found in subjects with seropositivity for both hepatitis B and C strains independently. Journal of Gastroenterology and Hepatology. 25: 1763-8. PMID 21039839 DOI: 10.1111/j.1440-1746.2010.06300.x  0.44
Show low-probability matches.